Simbec-Orion
Mark Bee is an experienced professional in the clinical research industry, currently serving as Vice President of Global Business Development at Simbec-Orion since January 2024. With over 19 years of expertise in CRO Business Development, Mark has held various leadership roles, including interim Head of Business Development and Marketing at tranScrip, and Vice President of Business Development for EU & APAC at Worldwide Clinical Trials. Mark is also a member of the Annual Conference Steering Committee for the PCMG Clinical Outsourcing Community, actively planning events since 2019. As the founder of Bee Clinical Consultancy, Mark advises small to mid-sized service providers on tailored commercial strategies. Mark's educational background includes a PhD in Molecular Pharmacology from UCL and a Bachelor of Science in Pharmacology from the University of Leeds.
This person is not in the org chart
This person is not in any offices
Simbec-Orion
2 followers
Simbec-Orion is a responsive and agile full-service CRO, with wide therapeutic experience and specialist expertise in clinical pharmacology, oncology and rare diseases. Structured to adapt quickly, we provide full-service clinical development solutions for small and mid-size drug developers – headed up by a centralised leadership team. With a focus on tailormade and scalable solutions, we’ll match our delivery style, communications and operations to suit the demands of your project, helping you achieve your clinical and commercial objectives. Because our goal is the same as yours; to improve patients’ lives.